Phase I/IIa study of TT-034, a DNA-directed RNA interference agent (ddRNAi) delivered as a single administration for the treatment of subjects with chronic hepatitis C virus (HCV)

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Suhy, D; Patel, K; Kilfoil, G; Wyles, DL; Naggie, S; Lawitz, E; Bradley, S; Lindell, P

Published Date

  • December 1, 2015

Published In

Volume / Issue

  • 62 / 6

Start / End Page

  • 1386A - 1386A

Published By

Pages

  • 1

Electronic International Standard Serial Number (EISSN)

  • 1527-3350

International Standard Serial Number (ISSN)

  • 0270-9139

Language

  • English